Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
March 28, 2025 21:35 ET | Source: Junshi Biosciences SHANGHAI, March 28,…
Data of InnoCare’s ICP-488 for the Treatment of Psoriasis Presented at Late Breaking Oral Presentation of 2025 AAD
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
SAN MATEO, Calif.--(BUSINESS WIRE)--$ONC #BeiGene--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235),…
HUTCHMED Announces Continued Inclusion of ORPATHYS (savolitinib) in the National Reimbursement Drug List in China at CurrentTerms
November 28, 2024 05:30 ET | Source: HUTCHMED (China) Limited HONG KONG…
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
November 16, 2024 02:53 ET | Source: Junshi Biosciences SHANGHAI, Nov. 16,…